Suttons Creek is Your Full-Service Combination Product Device Team

Bridging the gap between pharma and devices

Offering a wider scope of benefits as a proud member of the BlueRidge Life Sciences family of companies.

Develop and execute a phase-appropriate plan to get from clinical to launch.

Your early work paid off and you are now in Phase 1. You overcame formidable challenges and you’re in Phase 2. Your significant incremental investments enabled a Phase 3 study.

In these scenarios, and more, your experienced CMC and Leadership teams delivered success. Do you have a similarly accomplished and capable device team to drive success of the combination products that your patients will prefer and deliver the timelines that you need?

Regardless of your phase, there are activities needed to develop your combination product. Our experts will work with you to create and execute a phase-appropriate plan to get you there.

In fact, our team has supported over 120 combination product programs and can set up both your program and your company for success. We will develop and assess your strategic options, educate your teams and leadership, create your regulatory strategy, establish a compliant quality management system, select and manage vendors , and provide you an efficient and scalable device team based on your corporate goals and budgets.

We provide  Corporate Development to empower and enable your combination product program on top of expert Program Execution that will guide you through the key stages of successful combination product development, regulatory approval, and launch.

COMMON STARTUP PHARMA SERVICE PACKAGES

SCI packages that are generally engaged by Pharma companies who are building their first drug-device combination product program. A full list of our services can be found here.

 

Combination Product Startup

The first steps in creating a combination product start at the Executive Suite level. They are: identifying a cost-effective CP strategy that meets short- and long-term corporate goals, ensuring your leadership has the best practices inputs and practical knowledge needed to manage CP programs effectively, and setting up the organization’s structure and systems for success. Common deliverables include:

        Combination Product Readiness

        Once the Executive Team is armed with the knowledge and strategies that will guide the organization’s combination product development, attention must turn to the rest of the combination product team to ensure the appropriate CP knowledge base, team culture and collaboration system, and quality management system are in place. Our experts have taken many a Pharma start up from combination product idea to implementation and will help guide and execute the steps needed to get your company ready to begin. Common deliverables include:

        Combination Product Development

        Once combination product systems and team are in place and ready, the real work begins. Often, we are integrated into combination product organization startups to guide and support execution of device design and clinical development. Selecting the right device and vendors can be the deciding factor in the success of a combination product program and are almost always on the critical path. Our experts have worked on, and some have even regulated from within the FDA, most drug delivery device types in the market, and we have experience working with the industry’s top vendors , emerging technologies, and innovative companies. 

        With your desired timeline, technical and program needs, and supplier global risk management goals in mind, we help determine key metrics to select the partner(s) who will best meet your needs in current and future lifecycle steps, determine the most effective regulatory and clinical development pathways, and support execution of these strategies and management of vendors. And, most importantly, a full device team can be built to complete combination product development including preparation of relevant regulatory submission(s). Common deliverables include:

        Combination Product Commercialization

        Our team supports Pharma and their vendors in transition from clinical testing to commercial device readiness and through regulatory filing. As scale up and regulatory approval is in the works, our commercial experts step in to prepare your team for commercial launch and support your Commercial team’s postmarket responsibilities. Additionally, we can ensure your Quality Systems and processes are built to enable commercial success, including postmarket quality and safety events, postapproval change management, manufacturing changes, etc. Common deliverables include:

        To begin a conversation on how our experts can support your team, simply fill out our online contact form or call us directly at 877.611.4724.

        Not quite ready to reach out? Get in the combination product expert loop by connecting with us by following our LinkedIn company page or subscribing to receive our industry news emails.

        You can also find case studies and testimonials from your industry colleagues’ projects…

        Case Study: Organizational Roadblocks

        Case Study: Strategic Alignment

        Case Study: Regulatory Strategy

        Case Study: Device Platform Selection

        Case Study: Premarket Regulatory Issues

        Case Study: Vendor Relationship Management

        Case Study: Vendor Systems Readiness

        Case Study: Design + Development Pivot

        TESTIMONIALS

        Small Pharma | Senior VP

        Thank you for all of the critical support you’ve provided and for jumping in with a 110% commitment to helping us navigate this fire drill at all hours of the day! I know there’s still a lot of work ahead but getting a high quality 483 response document out today was a huge milestone and your contribution to this was vital.

        Small Pharma | Associate Director, Clinical Quality Operations

        SCI’s support has been integral in expanding our knowledge into the device space, as well as supporting us when we need on-site training.

        Startup Pharma | CEO

        Is this the point at which you should tell us, “we told you so”?” Thanks for your help on our FDA audit!

        Startup Pharma | CEO

        Suttons Creek exceeded expectations…indeed. However, I am not sure I was clear what the expectations were in the first place [due to] my lack of experience in this arena. I am sure that your team realized our adolescence and formed their approach appropriately. It was appreciated.

        Small Pharma | CMC

        Yes, [SCI has] added a lot of value and has also been very flexible as our business priorities shifted over time, which we appreciate very much!